The Global In Vitro Diagnostics Market is expected to exhibit a strong 8.16% CAGR over the forecast period from 2017 to 2023, according to the latest research report from Market Research Future (MRFR). The global in vitro diagnostics market is mainly driven by the growing government support for healthcare research into discovering more potent, more accurately targeted medication for various diseases. This is likely to drive significant innovation in the healthcare research sector in the coming years, thus driving the in vitro diagnostics market over the forecast period.
Segmentations for Global In Vitro Diagnostics Market
The global in vitro diagnostics market is segmented on the basis of product type, technology, application, end use, and region.
By product, the global in vitro diagnostics market is segmented into reagents and kits, instruments, data management software, and services. The reagents and kits segment is likely to establish dominance in the global in vitro diagnostics market over the forecast period due to the need to replenish reagents and kits on a regular basis.
By technology, the global in vitro diagnostics market is segmented into immunoassay/immunochemistry, clinical chemistry, molecular diagnostics, microbiology, and hematology. Clinical chemistry holds the largest share in the global in vitro diagnostics market, followed closely immunoassay/immunochemistry.
By application, the global market is segmented into infectious diseases and non-infectious diseases.
By end use, the global in vitro diagnostics market is segmented into hospitals, research laboratories, and academic institutions.
Get Exclusive Sample Copy of “In Vitro Diagnostics Market” Report @ https://www.marketresearchfuture.com/sample_request/1165
Market Overview and Factors
According to an eminent research firm – Market Research Future (MRFR), the global in-vitro diagnostics market is expected to rise to USD 102,555.24 MN by 2023, from USD 69,284.16 MN in 2017. In its recently published research, MRFR also asserts that the market would post a 6.5% CAGR during the review period (2018-2023). Tremendously popular, IVD devices perceive a considerable market demand, witnessing substantial technological advances in techniques and devices used for diagnosis.
In-vitro diagnostic helps early detection of a medical condition which further allows planning the line of treatment to manage the disease efficiently. IVD can also be used in next-generation sequencing tests in precision medicine to determine potentially effective therapies for patients, scanning their DNA and genomic variations. There is a massive demand for IVD devices in various regions to manage increasing chronic diseases and disorders.
Conversely, the lack of proper reimbursement policies in developing countries and stringent FDA norms are obstructing the growth of the market. Nevertheless, increasing government funding to encourage the adoption of the in-vitro diagnostic would support market growth over the forecast period.
Regional Analysis for Global In Vitro Diagnostics Market
North America leads the global in-vitro diagnostics market, accounting for over 39% of the total market. Rising prevalence of chronic diseases is contributing to the growth of the regional market. Increasing demand for advanced techniques in diagnostics and higher expenditure are the major factors supporting the growth of the regional market. Besides increasing the aged population in the region is a crucial demographic, encouraging the growth of the IVD market. Furthermore, the proliferation of precision medicines in the region is fostering the North American in-vitro diagnostics market, creating a huge demand.
Europe takes the second leading position in the global in-vitro diagnostics market. Initiatives and support from the governments and private health organizations are encouraging the regional market growth, raising awareness of point-of-care testing.
Moreover, the increasing healthcare budgets and focus on early diagnosis to manage chronic diseases well, are expected to help the region to retain its market position over the forecast period. The region is expected to show extensive growth throughout the forecast period, witnessing financial support from the government for R&D activities.
The in-vitro diagnostics market is brisk in Asia pacific, which offers promising growth opportunities for the market players. Increasing occurrences of chronic diseases alongside, the increasing numbers of private diagnostic centers in the region are driving the growth of the market.
Key Players for Global In Vitro Diagnostics Market
The key players operating in the Global In-Vitro Diagnostics Market and profiled in this MRFR report are
Players leading the global in-vitro diagnostics market include Abbott Laboratories, Thermo Fisher Scientific, DiaSorin S.p.A, Sysmex Corporation, Becton Dickinson and Company, BioMérieux S.A, Grifols S.A, Qiagen N.V., Ortho Clinical Diagnostics, Siemens AG, F. Hoffmann-La Roche AG, Danaher Corporation, and Bio-Rad Laboratories Inc., among others.
September 23, 2019 – SCIEX, a global leader in life science analytical technologies, announced that a suite of its medical devices has been approved by NVISA, the Brazilian Health Regulatory Agency. Brazil’s clinical diagnostics labs face significant challenges with increasing workloads, and a greater demand for rapid, accurate results.
In such a scenario, SCIEX’s accredited devices, including the QTRAP 4500MD LC-MS/MS, Triple Quad 4500MD LC-MS/MS, Topaz and Citrine systems, would enable it to meet the needs of Brazilian clinical labs to attain new quality standards in diagnostic testing. ANVISA approval would lead SCIEX to a new era in Brazil’s clinical in the in-vitro diagnostics field.
In-Vitro Diagnostics Market – Competitive Analysis
Highly competitive, the In-vitro diagnostics market appears to be fragmented due to the presence of several well-established players. To gain a substantially large market share, these players initiate strategic initiatives such as mergers & acquisitions, collaboration, expansion, and product launch, among others. Some of the players with international presence try to expand their footprint in developing regions.
This, as a result, makes it further difficult for the regional players to compete with them in terms of product portfolios, product differentiation, quality, and pricing. These players also create alliances with e-commerce partners and distribution agreements with strong local presence in regions such as Western Europe and APEJ.
Browse Complete “In Vitro Diagnostics Market” Report @ https://www.marketresearchfuture.com/reports/in-vitro-diagnostics-market-1165
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/in-vitro-diagnostics-market-1165